By: Emily MacHale
June 29, 2016
Tustin, CA – Integrium Clinical Research announced their on time screening goal completion for their phase I/II study for essential hypertension, with a total of 52 patients. The screenings were completed on two separate days within a two-week time frame, implementing 22 screenings on the first day and 30 screenings on the second day.
Greg’s role at Integrium is Senior Director, Business Development, with a focus in late phase clinical trials.
Greg’s favorite food is Chinese, specifically dim sum, and one of the many places he has traveled to is China! A fun fact about Greg is that he has a relative degree of fluency in Cantonese and he lived in Hong Kong for two years.
By Emily MacHale
June 6, 2016
Why are Ethnobridging clinical trials so vital in the biopharmaceutical industry today? Global companies are consistently collecting Japanese, Chinese, Taiwanese, and Korean early phase data in clinical development to fulfill specific goals.
